Magnesium sulfate and nifedipine on treatment of preterm labor
Phase 2
- Conditions
- Preterm labor and delivery.Preterm spontaneous labor with term delivery
- Registration Number
- IRCT2012062310089N1
- Lead Sponsor
- Vice Chancellor for Research, Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Singleton pregnancy, 24 to 37 weeks of gestation, signs of preterm labor.
Exclusion criteria : premature rupture of membrane, cervical dilatation > 4 cm, gestational age < 24 or >37 weeks, chorioamnionitis, vaginal bleeding, multiple pregnancy, previous cesarean section, previous uterus surgery, maternal or fetal indications for termination of pregnancy such as preeclampsia, fetal distress, fetal growth abnormalities and decreased blood pressure.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Delaying delivery up to 48 hours. Timepoint: Every 15 minutes until stopping of uterine contractions. Method of measurement: Abdominal palpation of uterus.
- Secondary Outcome Measures
Name Time Method Cervical dilatation. Timepoint: Every 2 hours until stopping of uterine contractions. Method of measurement: Vaginal examination.;Uterine contractions. Timepoint: Every 15 minutes until stopping of uterine contractions. Method of measurement: Abdominal palpation of uterus.;Cervical effacement. Timepoint: Every 2 hours until stopping of uterine contractions. Method of measurement: Vaginal examination.;Fetal complications. Timepoint: During drug administration. Method of measurement: Physician assessment.;Maternal complications. Timepoint: During drug administration. Method of measurement: Physician assessment.